
US regulator approves Pfizer BioNTech COVID-19 vaccine
The US Food and Drug Administration (FDA) has authorised the use of the Pfizer BioNTech mRNA vaccine, BNT162b2, against COVID-19 in individuals 16 years of age or older. The vaccine is authorized under an Emergency Use Authorization (EUA) while Pfizer and BioNTech gather additional data and prepare to file a… Read More















